Advagraf + Prograf + Corticosteroid + Mycophenolate mofetil
ApprovedCompleted 0 watching 0 views this week๐ฅ Hot
85
Development Stage
โ
Pre-clinicalโ
Phase 1โ
Phase 2โ
Phase 35
ApprovedIndication / Disease
de Novo Kidney Transplantation
Conditions
de Novo Kidney Transplantation
Trial Timeline
Apr 1, 2012 โ Jun 1, 2012
NCT ID
NCT01742624About Advagraf + Prograf + Corticosteroid + Mycophenolate mofetil
Advagraf + Prograf + Corticosteroid + Mycophenolate mofetil is a approved stage product being developed by Astellas Pharma for de Novo Kidney Transplantation. The current trial status is completed. This product is registered under clinical trial identifier NCT01742624. Target conditions include de Novo Kidney Transplantation.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01742624 | Approved | Completed |
Competing Products
19 competing products in de Novo Kidney Transplantation